Austin, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Bioprocess Bags Market Size & Growth Analysis
According to SNS Insider, The global Bioprocess Bags Market was valued at USD 3.50 billion in 2023, and is projected to reach USD 13.78 billion by 2032, growing at a strong CAGR of 16.46% between 2024 and 2032.
This acceleration reflects the worldwide shift toward single-use technologies (SUTs) as biopharmaceutical manufacturers prioritize operational efficiency, faster changeover times, lower contamination risk, and reduced infrastructure costs. The bioprocess bags market report highlights the direct correlation between rising biotech R&D investments, growth in biologics and cell/gene therapy pipelines, and the increasing deployment of scalable, flexible bioprocessing solutions. Moreover, the construction of new biomanufacturing facilities in emerging geographies and the increasing standardization of modular manufacturing platforms continue to reshape demand patterns across commercial, academic, and government end-users.
Get a Sample Report of Bioprocess Bags Market: https://www.snsinsider.com/sample-request/6853
The U.S. Bioprocess Bags Market alone is expected to grow from USD 0.77 billion in 2023 to USD 2.75 billion by 2032, at a CAGR of 15.28%, driven by strong biopharma concentration, advanced regulatory frameworks, and accelerating adoption of SUTs in GMP production.
Major Players Analysis Listed in the Bioprocess Bags Market Report are
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Danaher Corporation (via Cytiva and Pall Corporation)
- Merck KGaA (MilliporeSigma)
- Saint-Gobain
- Corning Incorporated
- Entegris
- Meissner Filtration Products, Inc.
- PROAnalytics, LLC
- CellBios Healthcare and Lifesciences Pvt Ltd.
Bioprocess Bags Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | USD 3.50 billion |
| Market Size by 2032 | USD 13.78 billion |
| CAGR | CAGR of 16.46% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Segments | • By Type [2D bioprocess bags, 3D bioprocess bags, Other bags & accessories] • By Workflow [Upstream Process, Downstream Process, Process Development] • By End User [Pharmaceutical and Biopharmaceutical Companies, CMOs & CROs, Academic Research Institutes] |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Segmentation Analysis:
By Type
In 2023, the market share of 2D bioprocess bags was nearly 42.8% more than in the whole segment due to how common media and buffer storage/sampling/process development are in the organization. The rapidly progressing segment is the 3D bioprocess bags, which is projected to grow with a high growth rate driven by the increased application in high-volume biomanufacturing processes.
By Workflow
The upstream process segment owned the workflow category share in the market with 40.6% of the market in 2023 due to the high intensity of use of bioprocess bags in cell culture, fermentation, and media prep, which is the most important activities of the Upstream supply chain. Downstream process segment is expected to grow at the fastest CAGR in the coming years, driven by the introduction of new purification technologies and the necessity for sterile fluid management.
By End-User
In 2023, the Pharmaceutical and biopharmaceutical companies were the largest end-users, accounting for 42.8% of the market share as they are the primary drivers of biologics production and have significantly adopted single-use technologies to streamline manufacturing, reduce contamination risks, and cut turnaround times. CMOs and CROs are the end-user segment that is assumed to be growing most rapidly. With more and more biopharma firms contracting to external development & manufacturing (cut costs and shorten time-to-market), CMOs and CROs adopt bioprocess bags, making them multi-product facilities with short manufacturing runs.
Purchase Single User PDF of Bioprocess Bags Market Report (20% Discount): https://www.snsinsider.com/checkout/6853
Regional Insights:
North America was considered the dominant region in the bioprocess bags market in 2023 owing to the existence of a state-of-the-art biopharmaceutical infrastructure system, high R&D expenses has been done, and wide use of single-use technologies.
Asia Pacific is going to rule the roost in terms of growth during the forecasted period due to the ramping up of biopharmaceutical manufacturing plants in China, India, and South Korea.
Recent Developments:
- In June 2024, Qosina partnered with Polestar Technologies to introduce iDOT Single-Use Sensor Bag Ports, expanding its single-use component portfolio. These gamma-stable, pre-calibrated ports enable non-invasive pH and dissolved oxygen monitoring in bioprocess bags and bioreactors, enhancing real-time process control.
- In Aug 2023, Kriya Therapeutics secured an additional USD 150 million in Series C funding to advance its gene therapies into clinical trials. This new investment will support the company's efforts to bring its gene therapies closer to market, accelerating their development.
Exclusive Sections of the Report (The USPs):
- ADOPTION RATE OF SINGLE-USE TECHNOLOGIES – helps you understand regional variations in the integration of single-use bioprocess bags, highlighting markets with rapid adoption and emerging opportunities for suppliers.
- BIOTECH R&D SPENDING ANALYTICS – provides insights into government, academic, and commercial R&D investments across key regions, helping you identify areas driving innovation and demand for advanced bioprocessing solutions.
- FACILITY EXPANSION & MANUFACTURING FOOTPRINT METRICS – tracks the establishment of new biomanufacturing sites between 2020–2024, allowing you to assess capacity growth and future supply potential by region.
- CUSTOM VS. STANDARD BAG DEMAND INDEX – helps you analyze the market shift toward customized bioprocess bag solutions versus standard formats, offering visibility into user preferences and design trends.
- TECHNOLOGY PENETRATION & INVESTMENT OPPORTUNITY MAP – highlights regions with increasing adoption of flexible bioprocessing systems and single-use components, guiding strategic investment and partnership decisions.
- END-USER SEGMENTATION INSIGHTS – enables evaluation of demand patterns across biopharma, academic, and contract manufacturing organizations (CMOs), supporting targeted market entry and growth strategies.
Need Any Customization Research on Bioprocess Bags Market, Enquire Now: https://www.snsinsider.com/enquiry/6853
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
